FDA Clears Pluristem Radiation Treatment for Emergency Use FDA Clears Pluristem Radiation Treatment for Emergency Use

Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Pharmacist News Alert Source Type: news